253 related articles for article (PubMed ID: 12044056)
21. The impact of KIR2DS4 alleles and the expression of KIR in the development of acute GVHD after unrelated allogeneic hematopoietic SCT.
Bao XJ; Hou LH; Sun AN; Qiu QC; Yuan XN; Chen MH; Chen ZX; He J
Bone Marrow Transplant; 2010 Sep; 45(9):1435-41. PubMed ID: 20062104
[TBL] [Abstract][Full Text] [Related]
22. Cytotoxic T lymphocyte precursor (CTL-p) frequency analysis in unrelated donor bone marrow transplantation: two case studies.
Kaminski ER; Hows JM; Bridge J; Davey NJ; Brookes PA; Green JE; Goldman JM; Batchelor JR
Bone Marrow Transplant; 1991 Jul; 8(1):47-50. PubMed ID: 1912955
[TBL] [Abstract][Full Text] [Related]
23. Three-dimensional structure discrepancy between HLA alleles for effective prediction of aGVHD severity and optimal selection of recipient-donor pairs: a proof-of-concept study.
Han H; Yuan F; Sun Y; Liu J; Liu S; Luo Y; Liang F; Liu N; Long J; Zhao X; Kong F; Xi Y
Oncotarget; 2015 Nov; 6(37):40337-59. PubMed ID: 26498683
[TBL] [Abstract][Full Text] [Related]
24. Immunogenetic factors in donors and patients that affect the outcome of hematopoietic stem cell transplantation.
Madrigal A; Shaw BE
Blood Cells Mol Dis; 2008; 40(1):40-3. PubMed ID: 17964196
[TBL] [Abstract][Full Text] [Related]
25. Relationship between CsA trough blood concentration and severity of acute graft-versus-host disease after paediatric stem cell transplantation from matched-sibling or unrelated donors.
Martin P; Bleyzac N; Souillet G; Galambrun C; Bertrand Y; Maire PH; Jelliffe RW; Aulagner G
Bone Marrow Transplant; 2003 Oct; 32(8):777-84. PubMed ID: 14520421
[TBL] [Abstract][Full Text] [Related]
26. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC
Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
[TBL] [Abstract][Full Text] [Related]
27. [Analysis of risk factors for the development of acute graft-versus-host disease in 151 cases of allo-hematopoietic stem cell transplantation].
Chen Y; Lu DP; Liu KY; Dong LJ; Ren HY; Huang XJ; Chen H; Liu DH; Jiang Q; Chen YH; Xu LP; Zhang YC; Lu J; Gao ZY
Zhonghua Xue Ye Xue Za Zhi; 2005 Feb; 26(2):74-7. PubMed ID: 15921621
[TBL] [Abstract][Full Text] [Related]
28. Incidence, risks, and outcome of idiopathic pneumonia syndrome early after allogeneic hematopoietic stem cell transplantation.
Zhu KE; Hu JY; Zhang T; Chen J; Zhong J; Lu YH
Eur J Haematol; 2008 Dec; 81(6):461-6. PubMed ID: 18774951
[TBL] [Abstract][Full Text] [Related]
29. Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors.
Teshima T; Matsuo K; Matsue K; Kawano F; Taniguchi S; Hara M; Hatanaka K; Tanimoto M; Harada M; Nakao S; Abe Y; Wake A; Eto T; Takemoto Y; Imamura M; Takahashi S; Ishida Y; Kanda Y; Kasai M; Takaue Y
Br J Haematol; 2005 Aug; 130(4):575-87. PubMed ID: 16098073
[TBL] [Abstract][Full Text] [Related]
30. Helper T lymphocyte precursor frequency analysis in alloreactivity detection.
Cukrová V; Dolezalová L; Loudová M; Vítek A
Neoplasma; 1998; 45(1):3-6. PubMed ID: 9604993
[TBL] [Abstract][Full Text] [Related]
31. [Relationship between the IFN-gamma producing cells specific for recipient and acute graft versus host disease].
Meng XJ; Lin MF; Cai Z
Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):95-8. PubMed ID: 16732961
[TBL] [Abstract][Full Text] [Related]
32. Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.
Gagne K; Busson M; Bignon JD; Balère-Appert ML; Loiseau P; Dormoy A; Dubois V; Perrier P; Jollet I; Bois M; Masson D; Moine A; Absi L; Blaise D; Charron D; Raffoux C;
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1366-75. PubMed ID: 19822295
[TBL] [Abstract][Full Text] [Related]
33. Pretransplant cytotoxic donor T-cell activity specific to patient HLA class I antigens correlating with mortality after unrelated BMT.
Speiser DE; Löliger CC; Siren MK; Jeannet M
Br J Haematol; 1996 Jun; 93(4):935-9. PubMed ID: 8703829
[TBL] [Abstract][Full Text] [Related]
34. NOD2 polymorphisms predict severe acute graft-versus-host and treatment-related mortality in T-cell-depleted haematopoietic stem cell transplantation.
van der Velden WJ; Blijlevens NM; Maas FM; Schaap NP; Jansen JH; van der Reijden BA; Feuth T; Dolstra H; Donnelly JP
Bone Marrow Transplant; 2009 Aug; 44(4):243-8. PubMed ID: 19219079
[TBL] [Abstract][Full Text] [Related]
35. [A method for modeling skin explants--an in vitro predictive test for graft vs host disease in allogenic hematopoietic cell transplantation].
Hromadníková I; Sedlácek P; Starý J; Vavrinec J; Cermáková-Frantlová M; Stechová K; Houbová B; Vítek A; Sajdová J; Sviland L; Dickinson AM
Cas Lek Cesk; 2001 Feb; 140(3):73-8. PubMed ID: 11284422
[TBL] [Abstract][Full Text] [Related]
36. Functional versus structural matching: can the CTLp test be replaced by HLA allele typing?
Oudshoorn M; Doxiadis II; van den Berg-Loonen PM; Voorter CE; Verduyn W; Claas FH
Hum Immunol; 2002 Mar; 63(3):176-84. PubMed ID: 11872235
[TBL] [Abstract][Full Text] [Related]
37. Homozygous status for HLA-E*0103 confers protection from acute graft-versus-host disease and transplant-related mortality in HLA-matched sibling hematopoietic stem cell transplantation.
Tamouza R; Busson M; Rocha V; Fortier C; Haddad Y; Brun M; Boukouaci W; Bleux H; Socié G; Krishnamoorthy R; Toubert A; Gluckman E; Charron D
Transplantation; 2006 Dec; 82(11):1436-40. PubMed ID: 17164714
[TBL] [Abstract][Full Text] [Related]
38. Translating in vitro prediction of cytotoxic T cell alloreactivity to hematopoietic stem cell transplantation outcome.
Jöris MM; Lankester AC; von dem Borne PA; Kuball J; Bierings M; Cornelissen JJ; Sijnke ME; van der Holt B; van Rood JJ; Oudshoorn M; Claas FH
Transpl Immunol; 2014 Mar; 30(2-3):59-64. PubMed ID: 24440708
[TBL] [Abstract][Full Text] [Related]
39. A novel approach to human leukocyte antigen-mismatched transplantation in patients with malignant hematological disease.
Huang XJ; Han W; Xu LP; Chen YH; Liu DH; Lu J; Chen H; Zhang YC; Jiang Q; Liu KY; Lu DP
Chin Med J (Engl); 2004 Dec; 117(12):1778-85. PubMed ID: 15603704
[TBL] [Abstract][Full Text] [Related]
40. Towards functional transplant donor matching by measurement of granzyme A and granzyme B production levels.
Kircher B; Hack CE; Dickinson AM; Wang XN; Oudshoorn M; Sachs A; Wolbink A; Niederwieser D; Eibl GJ; van Houwelingen HC; Goulmy E
J Immunol Methods; 2004 Oct; 293(1-2):51-9. PubMed ID: 15541276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]